Login / Signup
ImmTAV, a New Immunotherapy Targeting the Source of HBV Infection.
Antonio Bertoletti
Published in:
Hepatology (Baltimore, Md.) (2021)
Keyphrases
</>
hepatitis b virus
cancer therapy
liver failure
drug delivery